Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats

Combination of Mangiferin and Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Impaired Glucose Tolerance in Streptozotocin-Diabetic Rats

(2012) Jun Hou et al.   PHARMACOLOGY

Cardioprotective Effect of Mangiferin on Left Ventricular Remodeling in Rats

(2012) Dezhi Zheng et al.   PHARMACOLOGY

Overexpression of Human C-Reactive Protein Exacerbates Left Ventricular Remodeling in Diabetic Cardiomyopathy

(2011) Yoshinori Mano et al.   CIRCULATION JOURNAL

TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model

(2011) Yun Ti et al.   DIABETES

Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus: Is It Really the First Marker of Diabetic Cardiomyopathy?

(2011) Laura Ernande et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Tribulosin protects rat hearts from ischemia/reperfusion injury

(2010) Shuang Zhang et al.   ACTA PHARMACOLOGICA SINICA

Orexigenic effect of cocaine- and amphetamine-regulated transcript (CART) after injection into hypothalamic nuclei in streptozotocin-diabetic rats

(2010) Jun Hou et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus

(2009) Ying Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy

(2008) Sophie Linthout et al.   BASIC RESEARCH IN CARDIOLOGY

Effect of traditional Chinese medicine Shu-Mai-Tang on attenuating TNFα-induced myocardial fibrosis in myocardial ischemia rats

(2008) Hui-Qiu Yin et al.   JOURNAL OF ETHNOPHARMACOLOGY